Across TCGA pan-cancer cohorts, KRTDAP mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated KRTDAP data layer compared with 21 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher KRTDAP mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated KRTDAP expression acts as an unfavorable survival marker, although some lineages such as HNSC and LSCC show a favorable association.

HNSC, LSCC, and CCRCC are the cancer types where KRTDAP mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Quartile	II,III,IV	0.943	0.776	.005	25	view →
LSCC	DFS	Median	All	1.000	0.867	.006	4	view →
CCRCC	DFS	Median	All	1.000	0.357	.026	2	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: KRTDAP tumor-vs-normal RNA expression · all KRTDAP data types